34.09 -0.42 (-1.22%)
4.9M XNYS Volume
XNYS 19 Mar, 2025 4:01 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jeanne K. Mason | EVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.44 per share. | 06 Mar 2025 | 4,375 | 183,963 (0%) | 0% | 35.4 | 155,050 | Common Stock, $1 par value |
| Jeanne K. Mason | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 52,331 | 52,331 | - | - | Stock Option (Right to Buy) | |
| Jeanne K. Mason | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 15,696 | 199,659 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James Borzi | EVP,Chief Supply Chain Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 9,989 | 73,134 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James Borzi | EVP,Chief Supply Chain Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.44 per share. | 06 Mar 2025 | 3,262 | 63,145 (0%) | 0% | 35.4 | 115,605 | Common Stock, $1 par value |
| James Borzi | EVP,Chief Supply Chain Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 33,302 | 33,302 | - | - | Stock Option (Right to Buy) | |
| Joel T. Grade | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 29,538 | 118,434 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Joel T. Grade | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 98,478 | 98,478 | - | - | Stock Option (Right to Buy) | |
| Joel T. Grade | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.44 per share. | 06 Mar 2025 | 4,306 | 88,896 (0%) | 0% | 35.4 | 152,605 | Common Stock, $1 par value |
| Alok Sonig | EVP,Group President,Pharma | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 29,966 | 130,298 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Alok Sonig | EVP,Group President,Pharma | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 99,905 | 99,905 | - | - | Stock Option (Right to Buy) | |
| Alok Sonig | EVP,Group President,Pharma | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.44 per share. | 06 Mar 2025 | 10,839 | 100,332 (0%) | 0% | 35.4 | 384,134 | Common Stock, $1 par value |
| Anita A. Zielinski | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 17,123 | 17,123 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Heather L. Knight | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 118,934 | 118,934 | - | - | Stock Option (Right to Buy) | |
| Heather L. Knight | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 35,674 | 177,362 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Heather L. Knight | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.44 per share. | 06 Mar 2025 | 13,634 | 141,688 (0%) | 0% | 35.4 | 483,189 | Common Stock, $1 par value |
| David S. Rosenbloom | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 58,873 | 58,873 | - | - | Stock Option (Right to Buy) | |
| David S. Rosenbloom | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.44 per share. | 06 Mar 2025 | 4,922 | 104,780 (0%) | 0% | 35.4 | 174,436 | Common Stock, $1 par value |
| David S. Rosenbloom | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 17,658 | 122,438 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Reazur Rasul | EVP,Group Pres,Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 87,417 | 87,417 | - | - | Stock Option (Right to Buy) | |
| Reazur Rasul | EVP,Group Pres,Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.44 per share. | 06 Mar 2025 | 9,341 | 98,394 (0%) | 0% | 35.4 | 331,045 | Common Stock, $1 par value |
| Reazur Rasul | EVP,Group Pres,Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 26,220 | 124,614 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | EVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.86 per share. | 03 Mar 2025 | 1,479 | 188,339 (0%) | 0% | 34.9 | 51,558 | Common Stock, $1 par value |
| James Borzi | EVP,Chief Suppy Chain Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.86 per share. | 03 Mar 2025 | 1,339 | 66,407 (0%) | 0% | 34.9 | 46,678 | Common Stock, $1 par value |
| Alok Sonig | EVP,Group President,Pharma | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.86 per share. | 03 Mar 2025 | 1,936 | 111,171 (0%) | 0% | 34.9 | 67,489 | Common Stock, $1 par value |
| Heather L. Knight | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.86 per share. | 03 Mar 2025 | 3,344 | 155,323 (0%) | 0% | 34.9 | 116,572 | Common Stock, $1 par value |
| David S. Rosenbloom | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.86 per share. | 03 Mar 2025 | 1,312 | 109,703 (0%) | 0% | 34.9 | 45,736 | Common Stock, $1 par value |
| Reazur Rasul | EVP,Group Pres,Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.86 per share. | 03 Mar 2025 | 1,987 | 107,735 (0%) | 0% | 34.9 | 69,267 | Common Stock, $1 par value |
| Christopher A. Toth | EVP, Group Pres, Kidney Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.56 per share. | 31 Jan 2025 | 25,372 | 105,186 (0%) | 0% | 32.6 | 826,112 | Common Stock, $1 par value |
| Christopher A. Toth | EVP,Group Pres, Kidney Care | 31 Dec 2024 | 32,610 | 183,876 (0%) | 0% | 29.2 | 950,908 | Common Stock, $1 par value | |
| Jose E. Almeida | Chairman, CEO, President | 13 Dec 2024 | 5,966 | 243,589 (0%) | 0% | 30.3 | 180,889 | Common Stock, $1 par value | |
| Joel T. Grade | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.55 per share. | 02 Dec 2024 | 6,612 | 92,457 (0%) | 0% | 33.6 | 221,833 | Common Stock, $1 par value |
| Heather L. Knight | EVP, Group Pres, Med Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.55 per share. | 02 Dec 2024 | 6,041 | 157,674 (0%) | 0% | 33.6 | 202,676 | Common Stock, $1 par value |
| Reazur Rasul | EVP,Group Pres,Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.55 per share. | 02 Dec 2024 | 2,032 | 109,116 (0%) | 0% | 33.6 | 68,174 | Common Stock, $1 par value |
| Jeffrey A. Craig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2024 | 3,472 | 3,472 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James Borzi | EVP,Chief Supply Chain Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.85 per share. | 03 Sep 2024 | 1,685 | 66,853 (0%) | 0% | 37.8 | 63,777 | Common Stock, $1 par value |
| Alok Sonig | EVP,Group President, Pharma | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.85 per share. | 03 Sep 2024 | 3,054 | 111,603 (0%) | 0% | 37.9 | 115,594 | Common Stock, $1 par value |
| Christopher A. Toth | EVP,Group Pres, Kidney Care | 03 Jun 2024 | 15,202 | 213,282 (0%) | 0% | 34.1 | 518,084 | Common Stock, $1 par value | |
| David S. Rosenbloom | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.08 per share. | 03 Jun 2024 | 784 | 108,580 (0%) | 0% | 34.1 | 26,719 | Common Stock, $1 par value |
| Catherine R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 22,545 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Patricia B. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 21,367 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Peter M. Wilver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 13,267 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Stephen Newman Oesterle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 27,901 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 23,876 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 14,278 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Stephen H. Rusckowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 9,068 (0%) | 0% | 0 | Common Stock, $1 par value | |
| David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 16,274 (0%) | 0% | 0 | Common Stock, $1 par value | |
| William A. Ampofo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 9,847 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 47,630 | 188,481 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jose E. Almeida | Chairman, CEO, President | 06 Mar 2024 | 142,891 | 244,924 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| James Borzi | EVP,Chief Supply Chain Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 33,341 | 67,735 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Brian C. Stevens | SVP, CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 14,289 | 67,538 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Joel T. Grade | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 42,867 | 96,623 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Alok Sonig | EVP,Group President, Pharma | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 83,353 | 113,454 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Christopher A. Toth | EVP,Group Pres, Kidney Care | 06 Mar 2024 | 119,076 | 227,761 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Heather L. Knight | EVP,Group Pres,Med Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 107,168 | 160,330 (0%) | 0% | 0 | Common Stock, $1 par value | |
| David S. Rosenbloom | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 53,584 | 108,989 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Reazur Rasul | EVP,Group Pres, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 83,353 | 109,187 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jose E. Almeida | Chairman, CEO, President | 04 Mar 2024 | 4,779 | 102,033 (0%) | 0% | 42.5 | 203,108 | Common Stock, $1 par value | |
| Jeanne K. Mason | EVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.50 per share. | 04 Mar 2024 | 475 | 140,851 (0%) | 0% | 42.5 | 20,188 | Common Stock, $1 par value |
| James Borzi | EVP,Chief Supply Chain Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.50 per share. | 04 Mar 2024 | 420 | 34,394 (0%) | 0% | 42.5 | 17,850 | Common Stock, $1 par value |
| Brian C. Stevens | SVP, CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.50 per share. | 04 Mar 2024 | 545 | 53,249 (0%) | 0% | 42.5 | 23,163 | Common Stock, $1 par value |
| Heather L. Knight | EVP,Group Pres, Med Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.50 per share. | 04 Mar 2024 | 1,320 | 53,162 (0%) | 0% | 42.5 | 56,100 | Common Stock, $1 par value |
| Reazur Rasul | EVP, Group Pres, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.50 per share. | 04 Mar 2024 | 522 | 25,834 (0%) | 0% | 42.5 | 22,185 | Common Stock, $1 par value |
| Jeanne K. Mason | EVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.01 per share. | 01 Mar 2024 | 963 | 141,326 (0%) | 0% | 41.0 | 39,493 | Common Stock, $1 par value |
| Jeanne K. Mason | EVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 40.61 per share. | 01 Mar 2024 | 64,488 | 142,290 (0%) | 0% | 40.6 | 2,618,858 | Common Stock, $1 par value |
| Jeanne K. Mason | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.17 per share. | 01 Mar 2024 | 64,488 | 206,778 (0%) | 0% | 37.2 | 2,397,019 | Common Stock, $1 par value |
| Jose E. Almeida | Chairman, CEO, President | 01 Mar 2024 | 9,701 | 106,812 (0%) | 0% | 41.0 | 397,838 | Common Stock, $1 par value | |
| James Borzi | EVP, Chief Supply Chain Offcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.01 per share. | 01 Mar 2024 | 852 | 34,814 (0%) | 0% | 41.0 | 34,941 | Common Stock, $1 par value |
| Brian C. Stevens | SVP, CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.01 per share. | 01 Mar 2024 | 673 | 53,795 (0%) | 0% | 41.0 | 27,600 | Common Stock, $1 par value |
| Alok Sonig | EVP, Group President, Pharma | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.01 per share. | 01 Mar 2024 | 1,832 | 30,101 (0%) | 0% | 41.0 | 75,130 | Common Stock, $1 par value |
| Heather L. Knight | EVP, Group Pres, Med Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.01 per share. | 01 Mar 2024 | 2,154 | 54,483 (0%) | 0% | 41.0 | 88,336 | Common Stock, $1 par value |
| Jeanne K. Mason | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 64,488 | 0 | - | - | Stock Option (Right to Buy) | |
| David S. Rosenbloom | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.01 per share. | 01 Mar 2024 | 1,416 | 55,405 (0%) | 0% | 41.0 | 58,070 | Common Stock, $1 par value |
| Reazur Rasul | EVP, Group Pres, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.01 per share. | 01 Mar 2024 | 1,538 | 26,357 (0%) | 0% | 41.0 | 63,073 | Common Stock, $1 par value |
| Knight Heather L. | EVP, Group Pres, Med Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 1,027 | 56,958 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Reazur Rasul | EVP, Group Pres, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.31 per share. | 12 Feb 2024 | 248 | 27,895 (0%) | 0% | 40.3 | 9,997 | Common Stock, $1 par value |
| Almeida E. Jose | Chairman, CEO, President | 12 Feb 2024 | 32,884 | 127,376 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Borzi James | EVP, Chief Supply Chain Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 4,184 | 36,977 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James Borzi | EVP, Chief Supply Chain Office | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.31 per share. | 12 Feb 2024 | 1,311 | 35,666 (0%) | 0% | 40.3 | 52,846 | Common Stock, $1 par value |
| Rasul Reazur | EVP, Group Pres, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 716 | 28,143 (0%) | 0% | 0 | Common Stock, $1 par value | |
| E. Almeida Jose | Chairman, CEO, President | 12 Feb 2024 | 10,863 | 116,513 (0%) | 0% | 40.3 | 437,888 | Common Stock, $1 par value | |
| Heather Knight L. | EVP, Group Pres, Med Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.31 per share. | 12 Feb 2024 | 356 | 56,602 (0%) | 0% | 40.3 | 14,350 | Common Stock, $1 par value |
| Joel T. Grade | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 25,189 | 53,177 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Grade T. Joel | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 27,988 | 27,988 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Grade T. Joel | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 102,273 | 102,273 | - | - | Stock Option (Right to Buy) | |
| Brian Stevens C. | SVP, CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 13,994 | 53,532 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James Borzi | EVP, Chief Supply Chain Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 12,016 | 32,300 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Alok Sonig | EVP, Group President, Pharm | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.60 per share. | 01 Sep 2023 | 2,059 | 31,512 (0%) | 0% | 40.6 | 83,595 | Common Stock, $1 par value |
| Stephen H. Rusckowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2023 | 3,049 | 3,049 (0%) | 0% | 0 | Common Stock, $1 par value | |
| William A. Ampofo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 3,811 | 3,811 (0%) | 0% | 0 | Common Stock, $ par value | |
| Brian C. Stevens | SVP,Interim CFO,CAO&Cntrl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,909 | 38,982 (0%) | 0% | 0 | Common Stock, $1 par value | |
| David S. Rosenbloom | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.23 per share. | 01 Jun 2023 | 762 | 55,645 (0%) | 0% | 41.2 | 31,417 | Common Stock, $1 par value |
| A. Christopher Toth | EVP, Group Pres, Kidney Care | 01 Jun 2023 | 106,358 | 106,358 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Catherine R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,573 | 16,130 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Patricia B. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,573 | 14,984 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Peter M. Wilver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,573 | 7,111 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Stephen Newman Oesterle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,573 | 21,336 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,573 | 17,894 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,573 | 8,099 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Michael F. Mahoney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,573 | 9,692 (0%) | 0% | 0 | Common Stock, $1 par value | |
| David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,573 | 10,034 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Albert P L Stroucken | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.93 per share. | 20 Mar 2023 | 3,930 | 40,765 (0%) | 0% | 36.9 | 145,135 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Sale of securities on an exchange or to another person at price $ 37.52 per share. | 20 Mar 2023 | 3,930 | 36,835 (0%) | 0% | 37.5 | 147,454 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2023 | 3,930 | 0 | - | - | Stock Option (Right to Buy) | |
| Brian C. Stevens | SVP. CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.19 per share. | 20 Mar 2023 | 161 | 32,896 (0%) | 0% | 38.2 | 6,149 | Common Stock, $1 par value |
| Heather L. Knight | EVP, Group Pres, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.19 per share. | 20 Mar 2023 | 212 | 53,110 (0%) | 0% | 38.2 | 8,096 | Common Stock, $1 par value |
| Reaz Rasul | EVP, Group Pres, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.19 per share. | 20 Mar 2023 | 151 | 26,765 (0%) | 0% | 38.2 | 5,767 | Common Stock, $1 par value |
| Brian C. Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.94 per share. | 03 Mar 2023 | 184 | 33,058 (0%) | 0% | 39.9 | 7,349 | Common Stock, $1 par value |
| Heather L. Knight | EVP, Group Pres, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.94 per share. | 03 Mar 2023 | 220 | 53,322 (0%) | 0% | 39.9 | 8,787 | Common Stock, $1 par value |
| Reaz Rasul | EVP, Group Pres, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.94 per share. | 03 Mar 2023 | 148 | 26,917 (0%) | 0% | 39.9 | 5,911 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.62 per share. | 02 Mar 2023 | 460 | 138,821 (0%) | 0% | 39.6 | 18,225 | Common Stock, $1 par value |
| Jose E. Almeida | Chairman, CEO and President | 02 Mar 2023 | 4,642 | 408,453 (0%) | 0% | 39.6 | 183,916 | Common Stock, $1 par value | |
| James Borzi | SVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.62 per share. | 02 Mar 2023 | 474 | 20,078 (0%) | 0% | 39.6 | 18,780 | Common Stock, $1 par value |
| Brian C. Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.62 per share. | 02 Mar 2023 | 418 | 33,242 (0%) | 0% | 39.6 | 16,561 | Common Stock, $1 par value |
| James K. Saccaro | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.62 per share. | 02 Mar 2023 | 1,061 | 177,899 (0%) | 0% | 39.6 | 42,037 | Common Stock, $1 par value |
| Cristiano Franzi | SVP, President, EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.62 per share. | 02 Mar 2023 | 146 | 102,145 (0%) | 0% | 39.6 | 5,785 | Common Stock, $1 par value |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.62 per share. | 02 Mar 2023 | 271 | 22,625 (0%) | 0% | 39.6 | 10,737 | Common Stock, $1 par value |
| Heather L. Knight | EVP, Group Pres, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.62 per share. | 02 Mar 2023 | 1,067 | 53,543 (0%) | 0% | 39.6 | 42,275 | Common Stock, $1 par value |
| Reaz Rasul | EVP, Group Pres, Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.62 per share. | 02 Mar 2023 | 416 | 27,066 (0%) | 0% | 39.6 | 16,482 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 43,496 | 43,496 | - | - | Stock Option (Right to Buy) | |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 10,491 | 139,282 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jose E. Almeida | Chairman, CEO and President | 01 Mar 2023 | 281,445 | 281,445 | - | - | Stock Option (Right to Buy) | ||
| Jose E. Almeida | Chairman, CEO and President | 01 Mar 2023 | 67,884 | 413,096 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| James Borzi | SVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 35,820 | 35,820 | - | - | Stock Option (Right to Buy) | |
| James Borzi | SVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 8,640 | 20,552 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Brian C. Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 6,788 | 33,660 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Brian C. Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 14,072 | 14,072 | - | - | Stock Option (Right to Buy) | |
| James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 92,109 | 92,109 | - | - | Stock Option (Right to Buy) | |
| James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 22,217 | 178,961 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Alok Sonig | EVP, Group President, Pharm | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 63,965 | 63,965 | - | - | Stock Option (Right to Buy) | |
| Alok Sonig | EVP, Group President, Pharm | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 15,428 | 33,226 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 63,965 | 63,965 | - | - | Stock Option (Right to Buy) | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 24,685 | 102,292 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 15,428 | 77,607 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 25,586 | 25,586 | - | - | Stock Option (Right to Buy) | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 6,171 | 22,896 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Heather L. Knight | EVP, Group Pres, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 21,600 | 54,611 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Heather L. Knight | EVP, Group Pres, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 89,551 | 89,551 | - | - | Stock Option (Right to Buy) | |
| David S. Rosenbloom | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 13,885 | 56,101 (0%) | 0% | 0 | Common Stock, $1 par value | |
| David S. Rosenbloom | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 57,568 | 57,568 | - | - | Stock Option (Right to Buy) | |
| Steven Flynn | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 25,586 | 25,586 | - | - | Stock Option (Right to Buy) | |
| Steven Flynn | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 6,171 | 18,737 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Steven Flynn | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 12,343 | 31,080 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Reaz Rasul | EVP, Group Pres, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 15,428 | 27,482 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Reaz Rasul | EVP, Group Pres, Healthcare | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 63,965 | 63,965 | - | - | Stock Option (Right to Buy) | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 4,163 | 0 | - | - | Stock Option (Right to Buy) | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 40.50 per share. | 21 Feb 2023 | 3,813 | 16,725 (0%) | 0% | 40.5 | 154,427 | Common Stock, $1 par value |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.82 per share. | 21 Feb 2023 | 4,163 | 20,538 (0%) | 0% | 37.8 | 157,445 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 13 Feb 2023 | 1,061 | 128,791 (0%) | 0% | 40.5 | 42,971 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 3,621 | 129,852 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jose E. Almeida | Chairman, CEO and President | 13 Feb 2023 | 10,053 | 345,212 (0%) | 0% | 40.5 | 407,147 | Common Stock, $1 par value | |
| Jose E. Almeida | Chairman, CEO and President | 13 Feb 2023 | 31,044 | 355,265 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Brian C. Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 13 Feb 2023 | 224 | 26,872 (0%) | 0% | 40.5 | 9,072 | Common Stock, $1 par value |
| Brian C. Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 646 | 27,096 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 3,362 | 157,803 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James K. Saccaro | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 13 Feb 2023 | 1,059 | 156,744 (0%) | 0% | 40.5 | 42,890 | Common Stock, $1 par value |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 5,174 | 62,454 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 13 Feb 2023 | 275 | 62,179 (0%) | 0% | 40.5 | 11,138 | Common Stock, $1 par value |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 2,068 | 17,090 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 13 Feb 2023 | 715 | 16,375 (0%) | 0% | 40.5 | 28,958 | Common Stock, $1 par value |
| Steven Flynn | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 516 | 12,502 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 19,826 | 19,826 | - | - | Stock Option (Right to Buy) | |
| Jeanne K. Mason | SVP, Human Resources | Sale of securities on an exchange or to another person at price $ 44.70 per share. | 17 Jan 2023 | 59,477 | 126,231 (0%) | 0% | 44.7 | 2,658,622 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.82 per share. | 17 Jan 2023 | 59,477 | 185,708 (0%) | 0% | 37.8 | 2,249,420 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 19,825 | 39,652 | - | - | Stock Option (Right to Buy) | |
| Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 19,826 | 0 | - | - | Stock Option (Right to Buy) | |
| James Borzi | SVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.76 per share. | 01 Sep 2022 | 4,649 | 11,822 (0%) | 0% | 56.8 | 263,877 | Common Stock, $1 par value |
| David S. Rosenbloom | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 7,636 | 41,576 (0%) | 0% | 0 | Common Stock, $1 par value | |
| David S. Rosenbloom | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 33,442 | 33,442 | - | - | Stock Option (Right to Buy) | |
| David S. Rosenbloom | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 33,940 | 33,940 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Peter M. Wilver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 2,481 | 2,481 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Albert P L Stroucken | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 36,834 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Catherine R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 11,299 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Patricia B. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 10,178 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Thomas F. Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 15,740 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Stephen Newman Oesterle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 16,389 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Peter S. Hellman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 30,335 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 13,168 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 3,451 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Michael F. Mahoney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 5,004 (0%) | 0% | 0 | Common Stock, $1 par value | |
| David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 5,339 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Albert P L Stroucken | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.52 per share. | 05 Apr 2022 | 4,020 | 38,147 (0%) | 0% | 29.5 | 118,670 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Sale of securities on an exchange or to another person at price $ 75.76 per share. | 05 Apr 2022 | 2,805 | 35,342 (0%) | 0% | 75.8 | 212,507 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 4,020 | 0 | - | - | Stock Option (Right to Buy) | |
| Albert P L Stroucken | Director | Sale of securities on an exchange or to another person at price $ 76.63 per share. | 05 Apr 2022 | 1,215 | 34,127 (0%) | 0% | 76.6 | 93,105 | Common Stock, $1 par value |
| Peter S. Hellman | Director | Sale of securities on an exchange or to another person at price $ 75.76 per share. | 05 Apr 2022 | 2,827 | 28,822 (0%) | 0% | 75.8 | 214,174 | Common Stock, $1 par value |
| Peter S. Hellman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 4,020 | 0 | - | - | Stock Option (Right to Buy) | |
| Peter S. Hellman | Director | Sale of securities on an exchange or to another person at price $ 76.63 per share. | 05 Apr 2022 | 1,193 | 27,629 (0%) | 0% | 76.6 | 91,420 | Common Stock, $1 par value |
| Peter S. Hellman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.52 per share. | 05 Apr 2022 | 4,020 | 31,649 (0%) | 0% | 29.5 | 118,670 | Common Stock, $1 par value |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.52 per share. | 01 Apr 2022 | 1,005 | 28,034 (0%) | 0% | 29.5 | 29,668 | Common Stock, $1 par value |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 1,005 | 1,005 | - | - | Stock Option (Right to Buy) | |
| John D. Forsyth | Director | Sale of securities on an exchange or to another person at price $ 77.68 per share. | 01 Apr 2022 | 1,005 | 27,029 (0%) | 0% | 77.7 | 78,068 | Common Stock, $1 par value |
| Brian C. Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.05 per share. | 21 Mar 2022 | 157 | 25,993 (0%) | 0% | 79.1 | 12,411 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 23,428 | 23,428 | - | - | Stock Option (Right to Buy) | |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 5,054 | 126,153 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 31,008 | 31,008 | - | - | Stock Option (Right to Buy) | |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 6,688 | 52,632 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Giuseppe Accogli | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 11,891 | 76,495 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Giuseppe Accogli | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 55,126 | 55,126 | - | - | Stock Option (Right to Buy) | |
| Andrew Frye | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 34,454 | 34,454 | - | - | Stock Option (Right to Buy) | |
| Andrew Frye | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 7,432 | 22,002 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 2,973 | 14,976 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 13,781 | 13,781 | - | - | Stock Option (Right to Buy) | |
| Jose E. Almeida | Chairman, CEO and President | 02 Mar 2022 | 151,596 | 151,596 | - | - | Stock Option (Right to Buy) | ||
| Jose E. Almeida | Chairman, CEO and President | 02 Mar 2022 | 32,699 | 318,435 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| James Borzi | SVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 19,294 | 19,294 | - | - | Stock Option (Right to Buy) | |
| James Borzi | SVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 4,162 | 16,356 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 49,613 | 49,613 | - | - | Stock Option (Right to Buy) | |
| James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 10,702 | 154,276 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 8,175 | 56,365 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 37,899 | 37,899 | - | - | Stock Option (Right to Buy) | |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.52 per share. | 01 Mar 2022 | 1,005 | 28,034 (0%) | 0% | 29.5 | 29,668 | Common Stock, $1 par value |
| John D. Forsyth | Director | Sale of securities on an exchange or to another person at price $ 84.82 per share. | 01 Mar 2022 | 1,005 | 27,029 (0%) | 0% | 84.8 | 85,244 | Common Stock, $1 par value |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 1,005 | 2,010 | - | - | Stock Option (Right to Buy) | |
| Brian C. Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 3,567 | 17,406 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Brian C. Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.19 per share. | 28 Feb 2022 | 172 | 26,151 (0%) | 0% | 85.2 | 14,653 | Common Stock, $1 par value |
| Brian C. Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 8,269 | 8,269 | - | - | Stock Option (Right to Buy) | |
| Brian C. Stevens | SVP, CAO and Controller | Sale of securities on an exchange or to another person at price $ 85.46 per share. | 28 Feb 2022 | 2,325 | 14,186 (0%) | 0% | 85.5 | 198,695 | Common Stock, $1 par value |
| Brian C. Stevens | SVP, CAO and Controller | Sale of securities on an exchange or to another person at price $ 86.07 per share. | 28 Feb 2022 | 175 | 14,011 (0%) | 0% | 86.1 | 15,062 | Common Stock, $1 par value |
| Brian C. Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.97 per share. | 28 Feb 2022 | 172 | 13,839 (0%) | 0% | 85.0 | 14,615 | Common Stock, $1 par value |
| Brian C. Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 8,918 | 26,324 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | SVP, Human Resources | Sale of securities on an exchange or to another person at price $ 84.75 per share. | 14 Feb 2022 | 35,841 | 139,401 (0%) | 0% | 84.8 | 3,037,525 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 18,048 | 0 | - | - | Stock Option (Right to Buy) | |
| Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 18,048 | 18,048 | - | - | Stock Option (Right to Buy) | |
| Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 18,047 | 36,096 | - | - | Stock Option (Right to Buy) | |
| Jeanne K. Mason | SVP, Human Resources | Sale of securities on an exchange or to another person at price $ 85.54 per share. | 14 Feb 2022 | 18,302 | 121,099 (0%) | 0% | 85.5 | 1,565,553 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.95 per share. | 14 Feb 2022 | 54,143 | 175,242 (0%) | 0% | 31.0 | 1,675,726 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 3,853 | 123,332 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,334 | 119,479 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | SVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.75 per share. | 10 Feb 2022 | 2,233 | 121,099 (0%) | 0% | 87.8 | 195,946 | Common Stock, $1 par value |
| Jose E. Almeida | Chairman, CEO and President | 10 Feb 2022 | 23,230 | 285,736 (0%) | 0% | 87.8 | 2,038,433 | Common Stock, $1 par value | |
| Jose E. Almeida | Chairman, CEO and President | 10 Feb 2022 | 10,032 | 279,988 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Jose E. Almeida | Chairman, CEO and President | 10 Feb 2022 | 28,978 | 308,966 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 4,636 | 48,619 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Sean B.W. Martin | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.75 per share. | 10 Feb 2022 | 2,675 | 45,944 (0%) | 0% | 87.7 | 234,731 | Common Stock, $1 par value |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,604 | 43,983 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Brian C. Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 249 | 16,255 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Brian C. Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 724 | 16,979 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Brian C. Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.75 per share. | 10 Feb 2022 | 468 | 16,511 (0%) | 0% | 87.8 | 41,067 | Common Stock, $1 par value |
| James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 2,607 | 140,847 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 7,534 | 148,381 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James K. Saccaro | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.75 per share. | 10 Feb 2022 | 4,807 | 143,574 (0%) | 0% | 87.7 | 421,814 | Common Stock, $1 par value |
| Giuseppe Accogli | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 2,206 | 61,890 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Giuseppe Accogli | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.75 per share. | 10 Feb 2022 | 3,800 | 64,464 (0%) | 0% | 87.8 | 333,450 | Common Stock, $1 par value |
| Giuseppe Accogli | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 6,374 | 68,264 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Andrew Frye | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,404 | 10,514 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Andrew Frye | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 4,056 | 14,570 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,604 | 44,077 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.75 per share. | 10 Feb 2022 | 523 | 48,190 (0%) | 0% | 87.7 | 45,893 | Common Stock, $1 par value |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 4,636 | 48,713 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,030 | 9,371 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 599 | 11,254 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,738 | 12,992 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.75 per share. | 10 Feb 2022 | 989 | 12,003 (0%) | 0% | 87.8 | 86,785 | Common Stock, $1 par value |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.75 per share. | 10 Feb 2022 | 1,696 | 10,654 (0%) | 0% | 87.8 | 148,824 | Common Stock, $1 par value |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 2,979 | 12,350 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Thomas F. Chen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.03 per share. | 02 Feb 2022 | 1,680 | 14,667 (0%) | 0% | 35.0 | 58,850 | Common Stock, $1 par value |
| Thomas F. Chen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 1,680 | 0 | - | - | Stock Option (Right to Buy) | |
| Thomas F. Chen | Director | Sale of securities on an exchange or to another person at price $ 84.53 per share. | 02 Feb 2022 | 1,680 | 12,987 (0%) | 0% | 84.5 | 142,010 | Common Stock, $1 par value |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.52 per share. | 01 Feb 2022 | 1,005 | 28,034 (0%) | 0% | 29.5 | 29,668 | Common Stock, $1 par value |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 1,005 | 3,015 | - | - | Stock Option (Right to Buy) | |
| John D. Forsyth | Director | Sale of securities on an exchange or to another person at price $ 85.59 per share. | 01 Feb 2022 | 1,005 | 27,029 (0%) | 0% | 85.6 | 86,018 | Common Stock, $1 par value |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 738 | 1,477 | - | - | Stock Option (Right to Buy) | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.95 per share. | 07 Jan 2022 | 2,215 | 8,341 (0%) | 0% | 30.9 | 68,554 | Common Stock, $1 par value |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 739 | 0 | - | - | Stock Option (Right to Buy) | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 738 | 739 | - | - | Stock Option (Right to Buy) | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2021 | 743 | 743 (0%) | 0% | - | Common Stock, $1 par value | |
| Brian C. Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.05 per share. | 03 Dec 2021 | 3,050 | 15,978 (0%) | 0% | 78.1 | 238,053 | Common Stock, $1 par value |
| Sean B.W. Martin | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.77 per share. | 01 Nov 2021 | 21,450 | 63,731 (0%) | 0% | 50.8 | 1,089,017 | Common Stock, $1 par value |
| Sean B.W. Martin | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 21,450 | 61,749 | - | - | Stock Option (Right to Buy) | |
| Sean B.W. Martin | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 80.03 per share. | 01 Nov 2021 | 1,574 | 42,281 (0%) | 0% | 80.0 | 125,967 | Common Stock, $1 par value |
| Sean B.W. Martin | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 79.53 per share. | 01 Nov 2021 | 19,876 | 43,855 (0%) | 0% | 79.5 | 1,580,738 | Common Stock, $1 par value |
| James K. Saccaro | Executive VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.60 per share. | 01 Sep 2021 | 34,678 | 138,240 (0%) | 0% | 77.6 | 2,691,013 | Common Stock, $1 par value |
| Giuseppe Accogli | SVP, Pres, Amer, Global Bus | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.60 per share. | 01 Sep 2021 | 11,559 | 59,166 (0%) | 0% | 77.6 | 896,978 | Common Stock, $1 par value |
| Sean B.W. Martin | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 77.26 per share. | 02 Aug 2021 | 19,800 | 42,177 (0%) | 0% | 77.3 | 1,529,748 | Common Stock, $1 par value |
| Sean B.W. Martin | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 19,800 | 83,199 | - | - | Stock Option (Right to Buy) | |
| Sean B.W. Martin | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.77 per share. | 02 Aug 2021 | 19,800 | 61,977 (0%) | 0% | 50.8 | 1,005,246 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 2,230 | 34,126 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Catherine R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 2,230 | 8,475 (0%) | 0% | 0 | Common Stock, $1 par value | |
| John D. Forsyth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 1,116 | 35,315 (0%) | 0% | 0 | Common Stock, $1 par value | |
| John D. Forsyth | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2021 | 8,560 | 26,755 (0%) | 0% | 0 | Common Stock, $1 par value | |
| John D. Forsyth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 5,685 | 5,685 | - | - | Stock Option (Right to Buy) | |
| Patricia B. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 2,230 | 7,370 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Thomas T. Stallkamp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 2,230 | 11,576 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Thomas F. Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 2,230 | 12,857 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Stephen Newman Oesterle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 2,230 | 13,495 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Peter S. Hellman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 2,230 | 27,629 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 5,685 | 5,685 | - | - | Stock Option (Right to Buy) | |
| Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 1,116 | 10,365 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Michael F. Mahoney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 5,685 | 5,685 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 1,116 | 2,267 (0%) | 0% | 0 | Common Stock, $1 par value | |
| David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 2,230 | 2,597 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Andrew Frye | SVP, President, APAC | Sale of securities on an exchange or to another person at price $ 84.79 per share. | 12 Apr 2021 | 10,999 | 9,041 (0%) | 0% | 84.8 | 932,605 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.26 per share. | 05 Apr 2021 | 4,990 | 36,886 (0%) | 0% | 31.3 | 155,987 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 4,990 | 0 | - | - | Stock Option (Right to Buy) | |
| Albert P L Stroucken | Director | Sale of securities on an exchange or to another person at price $ 84.56 per share. | 05 Apr 2021 | 4,990 | 31,896 (0%) | 0% | 84.6 | 421,954 | Common Stock, $1 par value |
| Peter S. Hellman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.26 per share. | 05 Apr 2021 | 4,990 | 30,389 (0%) | 0% | 31.3 | 155,987 | Common Stock, $1 par value |
| Peter S. Hellman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 4,990 | 0 | - | - | Stock Option (Right to Buy) | |
| Peter S. Hellman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Apr 2021 | 5,293 | 5,293 | - | - | Stock Option (Right to Buy) | |
| Peter S. Hellman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Apr 2021 | 5,293 | 0 | - | - | Stock Option (Right to Buy) | |
| Peter S. Hellman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Apr 2021 | 6,138 | 6,138 | - | - | Stock Option (Right to Buy) | |
| Peter S. Hellman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Apr 2021 | 6,138 | 0 | - | - | Stock Option (Right to Buy) | |
| Peter S. Hellman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Apr 2021 | 6,437 | 6,437 | - | - | Stock Option (Right to Buy) | |
| Peter S. Hellman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Apr 2021 | 6,437 | 0 | - | - | Stock Option (Right to Buy) | |
| Peter S. Hellman | Director | Sale of securities on an exchange or to another person at price $ 84.56 per share. | 05 Apr 2021 | 4,990 | 25,399 (0%) | 0% | 84.6 | 421,954 | Common Stock, $1 par value |
| Brian C. Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.24 per share. | 22 Mar 2021 | 155 | 18,854 (0%) | 0% | 81.2 | 12,592 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 48,788 | 48,788 | - | - | Stock Option (Right to Buy) | |
| Jose E. Almeida | Chairman, CEO and President | 03 Mar 2021 | 348,483 | 348,483 | - | - | Stock Option (Right to Buy) | ||
| James Borzi | SVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 44,352 | 44,352 | - | - | Stock Option (Right to Buy) | |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 63,360 | 63,360 | - | - | Stock Option (Right to Buy) | |
| Brian C. Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 1,750 | 19,010 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Brian C. Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 17,424 | 17,424 | - | - | Stock Option (Right to Buy) | |
| James K. Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 82,369 | 82,369 | - | - | Stock Option (Right to Buy) | |
| Giuseppe Accogli | SVP, Pres, Amer, Global Bus | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 121,969 | 121,969 | - | - | Stock Option (Right to Buy) | |
| Andrew Frye | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 79,201 | 79,201 | - | - | Stock Option (Right to Buy) | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 79,201 | 79,201 | - | - | Stock Option (Right to Buy) | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 31,680 | 31,680 | - | - | Stock Option (Right to Buy) | |
| Brian C. Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.94 per share. | 01 Mar 2021 | 201 | 17,260 (0%) | 0% | 77.9 | 15,666 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.80 per share. | 16 Feb 2021 | 2,004 | 117,542 (0%) | 0% | 77.8 | 155,911 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 688 | 117,027 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,519 | 119,546 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 603 | 118,145 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jose E. Almeida | Chairman, CEO and President | 16 Feb 2021 | 4,535 | 266,818 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Jose E. Almeida | Chairman, CEO and President | 16 Feb 2021 | 5,510 | 264,126 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Jose E. Almeida | Chairman, CEO and President | 16 Feb 2021 | 20,160 | 284,286 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Jose E. Almeida | Chairman, CEO and President | 16 Feb 2021 | 22,003 | 262,283 (0%) | 0% | 77.8 | 1,711,833 | Common Stock, $1 par value | |
| Sean B.W. Martin | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.80 per share. | 16 Feb 2021 | 2,552 | 41,264 (0%) | 0% | 77.8 | 198,546 | Common Stock, $1 par value |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 726 | 41,990 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 3,225 | 43,816 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 881 | 40,591 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Brian C. Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 114 | 17,461 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James K. Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 1,179 | 172,458 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James K. Saccaro | Executive VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.80 per share. | 16 Feb 2021 | 4,308 | 171,279 (0%) | 0% | 77.8 | 335,162 | Common Stock, $1 par value |
| James K. Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 1,432 | 170,346 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James K. Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 5,241 | 175,587 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Giuseppe Accogli | SVP, Pres, Amer and Glbl Bus | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 998 | 70,140 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Giuseppe Accogli | SVP, Pres, Amer and Glbl Bus | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 1,101 | 68,283 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Giuseppe Accogli | SVP, Pres, Amer and Glbl Bus | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 4,032 | 72,315 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Giuseppe Accogli | SVP, Pres, Amer and Glbl Bus | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.80 per share. | 16 Feb 2021 | 3,173 | 69,142 (0%) | 0% | 77.8 | 246,859 | Common Stock, $1 par value |
| Andrew Frye | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 635 | 19,989 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Andrew Frye | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,419 | 19,354 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Andrew Frye | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 659 | 16,935 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,822 | 41,746 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.80 per share. | 16 Feb 2021 | 439 | 41,307 (0%) | 0% | 77.8 | 34,154 | Common Stock, $1 par value |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 726 | 42,033 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 770 | 38,924 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.80 per share. | 16 Feb 2021 | 1,064 | 5,387 (0%) | 0% | 77.8 | 82,779 | Common Stock, $1 par value |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 272 | 6,126 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 466 | 5,854 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 1,310 | 6,451 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 366 | 5,141 (0%) | 0% | 0 | Common Stock, $1 par value | |
| David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 366 | 366 (0%) | 0% | - | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Other type of transaction at price $ 0.00 per share. | 01 Oct 2020 | 2,449 | 0 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.26 per share. | 14 Sep 2020 | 310 | 34,279 (0%) | 0% | 31.3 | 9,691 | Common Stock, $1 par value |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 310 | 0 | - | - | Stock Option (Right to Buy) | |
| John D. Forsyth | Director | Sale of securities on an exchange or to another person at price $ 83.59 per share. | 14 Sep 2020 | 310 | 33,969 (0%) | 0% | 83.6 | 25,913 | Common Stock, $1 par value |
| James R. Gavin | Director | Other type of transaction at price $ 0.00 per share. | 11 Sep 2020 | 11,894 | 0 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| James Borzi | SVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2020 | 12,000 | 12,000 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James Borzi | SVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2020 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Cristiano Franzi | SVP, President, EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.55 per share. | 01 Sep 2020 | 1,132 | 38,036 (0%) | 0% | 85.6 | 96,843 | Common Stock, $1 par value |
| Thomas F. Chen | Director | Other type of transaction at price $ 0.00 per share. | 20 Aug 2020 | 3,386 | 0 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| Peter S. Hellman | Director | Other type of transaction at price $ 0.00 per share. | 20 Aug 2020 | 1,660 | 0 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| James R. Gavin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.50 per share. | 03 Aug 2020 | 10,789 | 54,407 (0%) | 0% | 37.5 | 404,588 | Common Stock, $1 par value |
| James R. Gavin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2020 | 10,789 | 0 | - | - | Stock Option (Right to Buy) | |
| James R. Gavin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2020 | 4,110 | 0 | - | - | Stock Option (Right to Buy) | |
| James R. Gavin | Director | Sale of securities on an exchange or to another person at price $ 86.91 per share. | 03 Aug 2020 | 3,351 | 39,508 (0%) | 0% | 86.9 | 291,235 | Common Stock, $1 par value |
| James R. Gavin | Director | Sale of securities on an exchange or to another person at price $ 86.26 per share. | 03 Aug 2020 | 11,548 | 42,859 (0%) | 0% | 86.3 | 996,130 | Common Stock, $1 par value |
| James R. Gavin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.83 per share. | 03 Aug 2020 | 4,110 | 43,618 (0%) | 0% | 39.8 | 163,701 | Common Stock, $1 par value |
| Giuseppe Accogli | SVP, President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.77 per share. | 19 Jun 2020 | 62,388 | 138,861 (0%) | 0% | 50.8 | 3,167,439 | Common Stock, $1 par value |
| Giuseppe Accogli | SVP, President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2020 | 62,388 | 31,195 | - | - | Stock Option [Right to Buy) | |
| Giuseppe Accogli | SVP, President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2020 | 8,334 | 0 | - | - | Stock Option (Right to Buy) | |
| Giuseppe Accogli | SVP, President, Americas | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 19 Jun 2020 | 72,341 | 66,520 (0%) | 0% | 85 | 6,148,985 | Common Stock, $1 par value |
| Giuseppe Accogli | SVP, President, Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.18 per share. | 19 Jun 2020 | 8,334 | 76,473 (0%) | 0% | 46.2 | 384,864 | Common Stock, $1 par value |
| John D. Forsyth | Director | Sale of securities on an exchange or to another person at price $ 82.95 per share. | 15 Jun 2020 | 1,500 | 33,898 (0%) | 0% | 83.0 | 124,425 | Common Stock, $1 par value |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2020 | 1,500 | 310 | - | - | Stock Option (Right to Buy) | |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.26 per share. | 15 Jun 2020 | 1,500 | 35,398 (0%) | 0% | 31.3 | 46,890 | Common Stock, $1 par value |
| Cristiano Franzi | SVP, President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2020 | 46,600 | 23,400 | - | - | Stock Option (Right to Buy) | |
| Cristiano Franzi | SVP, President, EMEA | Sale of securities on an exchange or to another person at price $ 87.96 per share. | 08 Jun 2020 | 22,700 | 39,088 (0%) | 0% | 88.0 | 1,996,692 | Common Stock, $1 par value |
| Cristiano Franzi | SVP, President, EMEA | Sale of securities on an exchange or to another person at price $ 87.33 per share. | 08 Jun 2020 | 23,900 | 61,788 (0%) | 0% | 87.3 | 2,087,187 | Common Stock, $1 par value |
| Cristiano Franzi | SVP, President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.23 per share. | 08 Jun 2020 | 46,600 | 85,688 (0%) | 0% | 62.2 | 2,899,918 | Common Stock, $1 par value |
| Andrew Frye | SVP, President, APAC | Sale of securities on an exchange or to another person at price $ 91.00 per share. | 03 Jun 2020 | 3,742 | 16,216 (0%) | 0% | 91 | 340,522 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 2,197 | 31,895 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Catherine R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 1,099 | 6,172 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Catherine R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 5,293 | 5,293 | - | - | Stock Option (Right to Buy) | |
| James R. Gavin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 2,197 | 39,402 (0%) | 0% | 0 | Common Stock, $1 par value | |
| John D. Forsyth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 2,197 | 33,898 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Patricia B. Morrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 2,197 | 5,080 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Thomas T. Stallkamp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 2,197 | 9,346 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Thomas F. Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 2,197 | 19,625 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Stephen N. Oesterle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 2,197 | 11,133 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Peter S. Hellman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 5,293 | 5,293 | - | - | Stock Option (Right to Buy) | |
| Peter S. Hellman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 1,099 | 25,399 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 5,293 | 5,293 | - | - | Stock Option (Right to Buy) | |
| Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 1,099 | 9,249 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Michael F. Mahoney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 5,293 | 5,293 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 1,099 | 1,137 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | SVP, Human Resources | Sale of securities on an exchange or to another person at price $ 93.74 per share. | 27 Apr 2020 | 8,669 | 116,339 (0%) | 0% | 93.7 | 812,632 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.97 per share. | 27 Apr 2020 | 47,146 | 163,485 (0%) | 0% | 29.0 | 1,365,820 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2020 | 47,176 | 0 | - | - | Stock Option (Right to Buy) | |
| Jeanne K. Mason | SVP, Human Resources | Sale of securities on an exchange or to another person at price $ 92.99 per share. | 27 Apr 2020 | 38,477 | 125,008 (0%) | 0% | 93.0 | 3,577,976 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.27 per share. | 01 Apr 2020 | 4,320 | 34,018 (0%) | 0% | 24.3 | 104,846 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Sale of securities on an exchange or to another person at price $ 78.79 per share. | 01 Apr 2020 | 1,300 | 32,718 (0%) | 0% | 78.8 | 102,427 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 01 Apr 2020 | 3,020 | 29,698 (0%) | 0% | 80 | 241,600 | Common Stock, $1 par value |
| Albert P L Stroucken | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2020 | 4,320 | 0 | - | - | Stock Option (Right to Buy) | |
| Peter S. Hellman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2020 | 4,320 | 0 | - | - | Common Stock, $1 par value | |
| Peter S. Hellman | Director | Sale of securities on an exchange or to another person at price $ 80.10 per share. | 01 Apr 2020 | 2,520 | 24,300 (0%) | 0% | 80.1 | 201,852 | Common Stock, $1 par value |
| Peter S. Hellman | Director | Sale of securities on an exchange or to another person at price $ 79.05 per share. | 01 Apr 2020 | 1,800 | 26,820 (0%) | 0% | 79.1 | 142,290 | Common Stock, $1 par value |
| Peter S. Hellman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.27 per share. | 01 Apr 2020 | 4,320 | 28,620 (0%) | 0% | 24.3 | 104,846 | Common Stock, $1 par value |
| Sean B.W. Martin | SVP and General Counsel | Purchase of securities on an exchange or from another person at price $ 82.19 per share. | 30 Mar 2020 | 9,780 | 39,504 (0%) | 0% | 82.2 | 803,818 | Common Stock, $1 par value |
| Jose E. Almeida | Chairman, CEO and President | 20 Mar 2020 | 381,437 | 381,437 | - | - | Stock Option (Right to Buy) | ||
| Brian Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2020 | 15,893 | 15,893 | - | - | Stock Option (Right to Buy) | |
| Brian Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2020 | 1,579 | 17,908 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Andrew Frye | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2020 | 57,216 | 57,216 | - | - | Stock Option (Right to Buy) | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2020 | 63,573 | 63,573 | - | - | Stock Option (Right to Buy) | |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 44,501 | 44,501 | - | - | Stock Option (Right to Buy) | |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 8,128 | 123,004 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 2,786 | 114,876 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | SVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.59 per share. | 19 Mar 2020 | 6,665 | 116,339 (0%) | 0% | 84.6 | 563,792 | Common Stock, $1 par value |
| Jose E. Almeida | Chairman, CEO and President | 19 Mar 2020 | 349,650 | 349,650 | - | - | Stock Option (Right to Buy) | ||
| Jose E. Almeida | Chairman, CEO and President | 19 Mar 2020 | 53,573 | 256,428 (0%) | 0% | 84.6 | 4,531,740 | Common Stock, $1 par value | |
| Jose E. Almeida | Chairman, CEO and President | 19 Mar 2020 | 58,065 | 310,001 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Jose E. Almeida | Chairman, CEO and President | 19 Mar 2020 | 19,898 | 251,936 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 79.94 per share. | 19 Mar 2020 | 1,500 | 8,150 (0%) | 0% | 79.9 | 119,910 | Common Stock, $1 par value |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 3,184 | 29,095 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 9,290 | 38,385 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Sean B.W. Martin | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.59 per share. | 19 Mar 2020 | 8,661 | 29,724 (0%) | 0% | 84.6 | 732,634 | Common Stock, $1 par value |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 50,858 | 50,858 | - | - | Stock Option (Right to Buy) | |
| James Saccaro | Executive VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.59 per share. | 19 Mar 2020 | 10,131 | 168,029 (0%) | 0% | 84.6 | 856,981 | Common Stock, $1 par value |
| James Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 12,774 | 178,160 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 4,377 | 165,386 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 41,322 | 41,322 | - | - | Stock Option (Right to Buy) | |
| Giuseppe Accogli | SVP, President, Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 95,359 | 95,359 | - | - | Stock Option (Right to Buy) | |
| Giuseppe Accogli | SVP, President, Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.59 per share. | 19 Mar 2020 | 8,620 | 67,740 (0%) | 0% | 84.6 | 729,166 | Common Stock, $1 par value |
| Giuseppe Accogli | SVP, President, Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 10,161 | 76,360 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Giuseppe Accogli | SVP, President, Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 3,483 | 66,199 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 25,429 | 25,429 | - | - | Stock Option (Right to Buy) | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.59 per share. | 19 Mar 2020 | 1,789 | 8,228 (0%) | 0% | 84.6 | 151,332 | Common Stock, $1 par value |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 2,903 | 10,017 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 1,025 | 7,114 (0%) | 0% | 0 | Common Stock, $1 par value | |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2020 | 1,500 | 1,810 | - | - | Stock Option (Right to Buy) | |
| John D. Forsyth | Director | Sale of securities on an exchange or to another person at price $ 76.70 per share. | 18 Mar 2020 | 1,500 | 31,638 (0%) | 0% | 76.7 | 115,050 | Common Stock, $1 par value |
| John D. Forsyth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.26 per share. | 18 Mar 2020 | 1,500 | 33,138 (0%) | 0% | 31.3 | 46,890 | Common Stock, $1 par value |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 1,773 | 110,393 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jeanne K. Mason | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 1,697 | 112,090 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jose E. Almeida | Chairman, CEO and President | 17 Mar 2020 | 14,182 | 219,279 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Jose E. Almeida | Chairman, CEO and President | 17 Mar 2020 | 12,759 | 232,038 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Sean B.W. Martin | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 17 Mar 2020 | 8,360 | 25,911 (0%) | 0% | 80.5 | 673,064 | Common Stock, $1 par value |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 2,041 | 34,271 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Sean B.W. Martin | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 2,270 | 32,230 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Brian Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 17 Mar 2020 | 169 | 16,329 (0%) | 0% | 80.5 | 13,606 | Common Stock, $1 par value |
| Brian Stevens | SVP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 318 | 16,498 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 3,317 | 161,009 (0%) | 0% | 0 | Common Stock, $1 par value | |
| James Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 3,687 | 157,692 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Giuseppe Accogli | SVP, President, Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 2,836 | 59,910 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Giuseppe Accogli | SVP, President, Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 2,806 | 62,716 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Andrew Frye | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 1,702 | 18,131 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Andrew Frye | SVP, President, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 1,786 | 19,917 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 1,985 | 36,961 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Cristiano Franzi | SVP, President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 2,041 | 39,002 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 922 | 4,012 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 766 | 6,089 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2020 | 1,311 | 5,323 (0%) | 0% | 0 | Common Stock, $1 par value | |
| John D. Forsyth | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.26 per share. | 13 Dec 2019 | 1,500 | 30,078 (0%) | 0% | 31.3 | 46,890 | Common Stock, $1 par value |
| John D. Forsyth | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2019 | 1,500 | 3,310 | - | - | Stock Option (Right to Buy) | |
| John D. Forsyth | None | Sale of securities on an exchange or to another person at price $ 83.64 per share. | 13 Dec 2019 | 1,500 | 31,578 (0%) | 0% | 83.6 | 125,460 | Common Stock, $1 par value |
| Brian Stevens | SVP, CAO and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.01 per share. | 03 Dec 2019 | 740 | 16,138 (0%) | 0% | 81.0 | 59,947 | Common Stock, $1 par value |
| Andrew Frye | SVP, President, APAC | Sale of securities on an exchange or to another person at price $ 88.00 per share. | 14 Oct 2019 | 3,332 | 16,391 (0%) | 0% | 88 | 293,216 | Common Stock, $1 par value |
| John D. Forsyth | None | Sale of securities on an exchange or to another person at price $ 87.76 per share. | 13 Sep 2019 | 180 | 31,521 (0%) | 0% | 87.8 | 15,797 | Common Stock, $1 par value |
| John D. Forsyth | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.26 per share. | 13 Sep 2019 | 180 | 31,701 (0%) | 0% | 31.3 | 5,627 | Common Stock, $1 par value |
| John D. Forsyth | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2019 | 180 | 4,810 | - | - | Stock Option (Right to Buy) | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 88.12 per share. | 05 Sep 2019 | 5,934 | 3,089 (0%) | 0% | 88.1 | 522,904 | Common Stock, $1 par value |
| Giuseppe Accogli | SVP, President, Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.78 per share. | 03 Sep 2019 | 2,285 | 56,730 (0%) | 0% | 87.8 | 200,577 | Common Stock, $1 par value |
| Cristiano Franzi | SVP, President, EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.78 per share. | 03 Sep 2019 | 402 | 34,833 (0%) | 0% | 87.8 | 35,288 | Common Stock, $1 par value |
| James R. Gavin | None | Sale of securities on an exchange or to another person at price $ 87.63 per share. | 19 Aug 2019 | 7,950 | 36,912 (0%) | 0% | 87.6 | 696,659 | Common Stock, $1 par value |
| James R. Gavin | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2019 | 3,930 | 0 | - | - | Stock Option (Right to Buy) | |
| James R. Gavin | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2019 | 4,020 | 0 | - | - | Stock Option (Right to Buy) | |
| James R. Gavin | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.93 per share. | 19 Aug 2019 | 3,930 | 44,862 (0%) | 0% | 36.9 | 145,135 | Common Stock, $1 par value |
| James R. Gavin | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.52 per share. | 19 Aug 2019 | 4,020 | 40,932 (0%) | 0% | 29.5 | 118,670 | Common Stock, $1 par value |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2019 | 13 | 3,652 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2019 | 13 | 3,640 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| James R. Gavin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2019 | 65 | 11,803 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| Thomas F. Chen | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2019 | 52 | 3,360 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2019 | 13 | 3,618 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Sale of securities on an exchange or to another person at price $ 80.46 per share. | 19 Jun 2019 | 593 | 9,023 (0%) | 0% | 80.5 | 47,713 | Common Stock, $1 par value |
| John D. Forsyth | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2019 | 1,320 | 0 | - | - | Stock Option (Right to Buy) | |
| John D. Forsyth | None | Sale of securities on an exchange or to another person at price $ 78.21 per share. | 13 Jun 2019 | 1,320 | 31,459 (0%) | 0% | 78.2 | 103,237 | Common Stock, $1 par value |
| John D. Forsyth | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.27 per share. | 13 Jun 2019 | 1,320 | 32,779 (0%) | 0% | 24.3 | 32,036 | Common Stock, $1 par value |
| Jacqueline Kunzler | SVP, Chief Quality Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 14 | 3,606 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| James R. Gavin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2019 | 70 | 11,714 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| Thomas F. Chen | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2019 | 56 | 3,301 | - | - | Deferred Comp Plan Baxter Common Stock Fund | |
| Albert P L Stroucken | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2019 | 2,412 | 29,698 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Catherine R. Smith | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2019 | 1,206 | 5,020 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Catherine R. Smith | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2019 | 6,138 | 6,138 | - | - | Stock Option (Right to Buy) | |
| James R. Gavin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2019 | 2,412 | 36,813 (0%) | 0% | 0 | Common Stock, $1 par value | |
| John D. Forsyth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2019 | 1,206 | 31,459 (0%) | 0% | 0 | Common Stock, $1 par value | |
| John D. Forsyth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2019 | 6,138 | 6,138 | - | - | Stock Option (Right to Buy) | |
| Patricia B. Morrison | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2019 | 2,412 | 2,856 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Thomas T. Stallkamp | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2019 | 2,412 | 7,149 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Thomas F. Chen | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2019 | 2,412 | 17,245 (0%) | 0% | 0 | Common Stock, $1 par value |